Related Experiment Video
Updated: Aug 25, 2026
Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
Published on: February 8, 2022
Characterization of stem cell factor gene-modified human natural killer cell line, NK-92 cells: implication in NK
Jian Zhang1, Rui Sun, Haiming Wei
1School of Life Sciences, University of Science and Technology of China, Hefei City, Anhui 230027, PR China.
Abstract:
NK-92 cells are effective against a broad range of malignant targets both in vitro and in vivo. Stem cell factor (SCF) is an important early acting cytokine for NK cell development. The characterization and implication in clinic of SCF gene-modified NK-92 cells need to be investigated. SCF cDNA was inserted into pcDNA3 eukaryotic expression vector and the recombinant vector (pcDNA3-SCF) was transfected into NK-92 cells. The SCF gene-modified NK-92 cells (NK92-SCF) were cloned and characterized by cytokine gene expression, proliferation potential, cytotoxic function and surface phenotype. NK92-SCF cells continuously produced a high level of SCF in culture supernatant, which made the cells proliferate significantly more rapidly in response to IL-2 or IL-15 stimulation, the cumulative amount of cells in long-term culture was significantly higher. NK92-SCF cells exerted stronger cytotoxicity against a broad range of target tumor cells than their parent NK-92 cells, which was correlated to the increased expression of cytotoxic effector molecules such as perforin and Fas ligand. NK92-SCF cells became more heterogeneous; the CD56(High) and CD56(Low) subsets appeared, which may, at least partly, explain the increased proliferating and cytotoxic potential of NK92-SCF cells. SCF gene-modified NK-92 cells (NK92-SCF cells) are more promising than their parent cells for adoptive cellular immunotherapy.
Insights
Genetically modifying Natural Killer-92 (NK-92) cells to produce stem cell factor (SCF) significantly enhances their proliferation and cancer-killing abilities. These modified NK92-SCF cells show greater promise for adoptive cellular immunotherapy against various cancers.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Natural Killer-92 (NK-92) cells are potent cytotoxic lymphocytes effective against diverse malignancies.
- Stem cell factor (SCF) is a crucial cytokine for NK cell development and function.
- Investigating SCF gene-modified NK-92 cells is essential for advancing immunotherapy.
Purpose of the Study:
- To engineer NK-92 cells to express Stem Cell Factor (SCF).
- To characterize the functional implications of SCF gene modification in NK-92 cells.
- To evaluate the potential of SCF-modified NK-92 cells for adoptive cellular immunotherapy.
Main Methods:
- SCF cDNA was cloned into a pcDNA3 vector for transfection into NK-92 cells, creating NK92-SCF cells.
- Characterization involved assessing cytokine gene expression, proliferation, cytotoxicity, and surface phenotype.
- Long-term cultures and stimulation with IL-2/IL-15 were used to evaluate cell expansion and function.
Main Results:
- NK92-SCF cells continuously produced high levels of SCF, leading to significantly enhanced proliferation with IL-2/IL-15 stimulation.
- Modified cells exhibited superior cytotoxicity against a broad spectrum of tumor targets, correlated with increased perforin and Fas ligand expression.
- NK92-SCF cells displayed increased heterogeneity, including CD56(High) and CD56(Low) subsets, potentially explaining enhanced capabilities.
Conclusions:
- SCF gene modification substantially improves the proliferative and cytotoxic potential of NK-92 cells.
- NK92-SCF cells demonstrate enhanced anti-tumor activity compared to parent NK-92 cells.
- SCF-modified NK-92 cells represent a more promising candidate for adoptive cellular immunotherapy.
